Published in:
Open Access
01-03-2014 | Poster discussion presentation
PD42 - Is rituximab a trigger for persistent hypogammaglobulinemia in idiopathic nephrotic syndrome?
Authors:
Juan Enrique Trujillo, Montserrat Bosque, Òscar Asensio, Adrián Ranera, Juan Cristobal Rojo, Mireia Vilella, Elisabet Guijarro, Xavier Domingo, Laura Valdesoiro, Helena Larramona
Published in:
Clinical and Translational Allergy
|
Special Issue 1/2014
Login to get access
Excerpt
Rituximab (RTX) is a monoclonal antibody; recently it has been use as a new treatment strategy in patients with high-degree steroid-dependent nephrotic syndrome. It provokes a lymphocyte B depletion in some cases that interacts with Immunoglobulins creating decreased plasma IgG levels and hypogammaglobulinemia. …